Rab5if is a potential therapeutic target of NSCLC

Authors

Institutions

Publication Details

Journal
Cancer Genetics
Published
2025-04-25
DOI
https://doi.org/10.1016/j.cancergen.2025.04.005
Citations
2
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rab5if is a potential therapeutic target of NSCLC

Linjuan Lu, Lixiu Chen, Feng Gao, Chunming Xu et al.
2 citations
Cancer Genetics
Ubiquitin and proteasome pathways
1.61
article

Rab5if is a potential therapeutic target of NSCLC

Linjuan Lu, Lixiu Chen, Feng Gao, Chunming Xu, Chen Ni, Wenxia Qian
article en
2 citations

Abstract

No abstract available for this paper.
Cancer GeneticsVol. 294-295
Soochow University (CN), Zhangjiagang First People's Hospital (CN)
Openalex Percentile: Top 18%
Ubiquitin and proteasome pathways
1.61
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Rab5if is a potential therapeutic target of NSCLC — Linjuan Lu, Lixiu Chen, et al. · Cancer Genetics (2025) | TGRS Research Map | TGRS